Phase II study of trastuzumab biosimilar (Herzuma (R)) plus gedatolisib in patients with HER-2 positive metastatic breast cancer who progressed after 2 or more HER-2 directed chemotherapy (BR 18-13, KM-10A): Interim analysisJu Won Kim,Hee Kyung Ahn,Jong Gwon Choi,Yee Soo Chae,Gyeong-Won Lee,Keon Uk Park,Eunmi Lee,Sung Hoon Sim,Jee Hyun Kim,Yeon Hee Park,Miso Kim,Jin Hyun Park,Jeong Eun Kim,Han Jo Kim,Mi Sun Ahn,So Yeon Oh,Min Hwan Kim,Su-Jin Koh,Kyoung Eun Lee,Myoung Joo Kang,Jae Ho Byun,Joo Young Ha,Jung Hye Kwon,Joo Young Jung,Su Ee Lee,Inhae Park,Kyong Hwa ParkCANCER RESEARCH（2022）引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
